Seizures in alzheimer disease: Clinical and epidemiological data

Epilepsy Currents

Volumn 12, Issue 5, 2012, Pages 184-187

  Pandis, Dionysios ^a   Scarmeas, Nikolaos ^a,b,c  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b NewYork Presbyterian Hospital   (United States)

^c Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ALZHEIMER DISEASE; ANTICONVULSANT THERAPY; ARTICLE; ATTENTION; AUTOPSY; COHORT ANALYSIS; DISEASE SEVERITY; DIZZINESS; DOWN SYNDROME; ELECTROENCEPHALOGRAPHY; FOLLOW UP; HALLUCINATION; HUMAN; HYPONATREMIA; LETHARGY; OBSERVATIONAL STUDY; OSTEOPENIA; PROFESSIONAL KNOWLEDGE; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SEIZURE; TEMPORAL LOBE EPILEPSY; TREMOR; UNSTEADINESS;

EID: 84870314387     PISSN: 15357597     EISSN: 15357511     Source Type: Journal    
DOI: 10.5698/1535-7511-12.5.184     Document Type: Article

References (45)

1. Alzheimer's Association, Thies W, Bleiler L. 2011 Alzheimer's disease facts and figures. Alzheimers Dement. 2011 Mar; 7 (2):208-44.
2. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the "common" neurologic disorders? Neurology 2007;68:326-337.
3. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993;34:453-468.
4. Sjogren T, Sjogren H, Lindgren AG. Morbus Alzheimer and morbus Pick: A genetic, clinical and patho-anatomical study. Acta Psychiatr Neurol Scand Suppl 1952;82:1-152.
5. Hauser WA, Morris ML, Heston LL, Anderson VE. Seizures and myoclonus in patients with Alzheimer's disease. Neurology 1986;36:1226-1230.
6. Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA. Dementia and adult-onset unprovoked seizures. Neurology 1996;46:727-730.
7. Risse SC, Lampe TH, Bird TD, Nochlin D, Sumi SM, Keenan T, Cubberley L, Peskind E, Raskind MA. Myoclonus, seizures, and paratonia inAlzheimer disease. Alzheimer Dis Assoc Disord 1990;4:217-225.
8. Sulkava R. Alzheimer's disease and senile dementia of Alzheimer type: A comparative study. Acta Neurol Scand 1982;65:636-650.
9. Mcareavey MJ, Ballinger BR, Fenton GW. Epileptic seizures in elderly patients with dementia. Epilepsia 1992;33:657-660.
10. Mendez MF, Catanzaro P, Doss RC, ARguello R, Frey WH II. Seizures in Alzheimer's disease: Clinicopathologic study. J Geriatr Psychiatry Neurol 1994;7:230-233.
11. Romanelli MF, Morris JC, Ashkin K, Coben LA. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol 1990;47:847-850.
12. Amatniek JC, Hauser WA, DelCastillo-castaneda C, Jacobs DM, Marder K, Bell K, Albert M, Brandt J, Stern Y. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 2006;47:867-872.
13. Volicer L, Smith S, Volicer BJ. Effect of seizures on progression of dementia of the Alzheimer type. Dementia 1995;6:258-263.
14. Lozsadi DA, Larner AJ. Prevalence and causes of seizures at the time of diagnosis of probable Alzheimer's disease. Dement Geriatr Cogn Disord 2006;22:121-124.
15. Rao SC, Dove G, Cascino GD, Petersen RC. Recurrent seizures in patients with dementia: Frequency, seizure types, and treatment outcome. Epilepsy Behav 2009;14:118-120.
16. Bernardi S, Scaldaferri N, Vanacore N, Trebbastoni A, Francia A, D'Amico A, Prencipe M. Seizures in Alzheimer's disease: A retrospective study of a cohort of outpatients. Epileptic Disord 2010;12:16-21.
17. Scarmeas N, Honig LS, Choi H, Cantero J, Brandt J, Blacker D, Albert M, Amatniek JC, Marder K, Bell K, Hauser WA, Stern Y Seizures in Alzheimer disease: Who, when, and how common? Arch Neurol 2009; 66:992-997.
18. Irizarry MC, Jin S, He F, Emond JA, Raman R, Thomas RG, Sano M, Quinn JF, Tariot PN, Galasko DR, Ishihara LS, Weil JG, Aisen PS. Incidence of new-onset seizures in mild to moderate Alzheimer disease. Arch Neurol 2012; 69:368-372.
19. Blum DE, Eskola J, Bortz JJ, Fisher RS. Patient awareness of seizures. Neurology 1996;47:260-264.
20. Hoppe C, Poepel A, Elger CE. Epilepsy: Accuracy of patient seizure counts. Arch Neurol 2007;64:1595-1599.
21. Zeman AZ, Boniface SJ, Hodges JR. Transient epileptic amnesia: A description of the clinical and neuropsychological features in 10 cases and a review of the literature. J Neurol Neurosurg Psychiatry 1998;64:435-443.
22. Rabinowicz AL, Starkstein SE, Leiguarda RC, Coleman AE. Transient epileptic amnesia in dementia: A treatable unrecognized cause of episodic amnestic wandering. Alzheimer Dis Assoc Disord 2000;14:231-233.
23. Larner AJ, Doran M. Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. J Neurol 2006;253:139-158.
24. Jayadev S, Leverenz JB, Steinbart E, Stahl J, Klunk W, Yu CE, Bird TD.Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. Brain 2010;133(pt 4):1143-1154.
25. Cabrejo L, Guyant-marechal L, Laquerriere A, Vercelletto M, De La Fourniere F, Thomas-anterion C, Verny C, Letournel F, Pasquier F, Vital A, Checler F, Frebourg T, Campion D, Hannequin D. Phenotype associated with APP duplication in five families. Brain 2006;129:2966-2976.
26. Menendez M. Down syndrome, Alzheimer's disease and seizures. Brain Dev 2005;27:246-252.
27. Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 1989;46:849-853.
28. Forstl H, Burns A, Levy R, Cairns N, Luthert P, Lantos P. Neurologic signs in Alzheimer's disease: Results of a prospective clinical and neuropathologic study. Arch Neurol 1992;49:1038-1042.
29. Mendez M, Lim G. Seizures in elderly patients with dementia: Epidemiology and management. Drugs Aging 2003;20:791-803.
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
31. Heyman A, Wilkinson WE, Hurwitz BJ, Helms MJ, Haynes CS, Utley CM, Gwyther LP. Early-onset Alzheimer's disease: Clinical predictors of institutionalization and death. Neurology 1987;37:980-984.
32. Hamberger MJ, Palmese CA, Scarmeas N, Weintraub D, Choi H, Hirsch LJ. A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in epilepsy. Epilepsia 2007;48:1283-1291.
33. Babiloni C, Carducci F, Lizio R, Vecchio F, Baglieri A, Bernardini S, Cavedo E, Bozzao A, Buttinelli C, Esposito F, Giubilei F, Guizzaro A, Marino S, Montella P, Quattrocchi CC, Redolfi A, Soricelli A, Tedeschi G, Ferri R, Rossi-Fedele G, Ursini F, Scrascia F, Vernieri F, Pedersen TJ, Hardemark HG, Rossini PM, Frisoni GB. Resting state cortical electroencephalographic rhythms are related to gray matter volume in subjects with mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp 2012 Feb 14. In press
34. Smits LL, Liedorp M, Koene T, Roos-reuling IE, Lemstra AW, Scheltens P, Stam CJ, van der Flier WM EEG abnormalities are associated with different cognitive profiles in Alzheimer's disease. Dement Geriatr Cogn Disord 2011;31:1-6.
35. Liedorp M, Stam CJ, van der Flier WM, Pijnenburg YA, Scheltens P. Prevalence and clinical significance of epileptiform EEG discharges in a large memory clinic cohort. Dement Geriatr Cogn Disord 2010;29:432-437.
36. Sadler RM, Goodwin J. Multiple electrodes for detecting spikes in partial complex seizures. Can J Neurol Sci 1989;16:326-329.
37. Rowan AJ, Ramsay RE, Collins JF, Pryor F, Boardman KD, Uthman BM, Spitz M, Frederick T, Towne A, Carter GS, Marks W, Felicetta J, Tomyanovich ML; VA Cooperative Study 428 Group New onset geriatric epilepsy: A randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005;64:1868-1873.
38. Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 1999;37:81-87.
39. Saetre E, Perucca E, Isojarvi J, Gjerstad L. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 2007;48:1292-1302.
40. Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, Peter D. Williamson, M.D., David M. Treiman, M.D., James O. McNamara, M.D., Charlotte B. McCutchen, M.D., Richard W. Homan, M.D., Wayne E. Crill, M.D., Michael F. Lubozynski, M.D., N. Paul Rosenthal, M.D., and Assa Mayersdorf, M.D Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145-151.
41. Werhahn KJ. Epilepsy in the elderly. Dtsch Arztebl Int 2009;106:135-142.
42. Tariot PN, Raman R, Jakimovich L, Schneider L, Porsteinsson A, Thomas R, Mintzer J, Brenner R, Schafer K, Thal L; Alzheimer's Disease Cooperative Study; Valproate Nursing Home Study Group. Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: A randomized, controlled trial. Am J Geriatr Psychiatry 2005;13:942-949.
43. Fleisher AS, Truran D, Mai JT, Langbaum JB, Aisen PS, Cummings JL, Jack CR Jr, Weiner MW, Thomas RG, Schneider LS, Tariot PN Chronic divalproex sodium use and brain atrophy in Alzheimer disease. Neurology 2011;77:1263-1271.
44. Wu CS, Wang SC, Chang IS, Lin KM. The association between dementia and long-term use of benzodiazepine in the elderly:Nested case-control study using claims data. Am J Geriatr Psychiatry 2009;17:614-620.
45. Griffiths RR, Weerts EM. Benzodiazepine self-administration in humans and laboratory animals-implications for problems of long-term use and abuse. Psychopharmacology (Berl) 1997;134:1-37.